U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Mon Mar 31 22:48:47 GMT 2025
Edited
by admin
on Mon Mar 31 22:48:47 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG4
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
10E3O6YI4W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RINUCUMAB
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
REGN-2176
Preferred Name English
IMMUNOGLOBULIN G4, ANTI-(HUMAN PLATELET-DERIVED GROWTH FACTOR RECEPTOR~) (HUMAN MONOCLONAL REGN2176 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2176 K-CHAIN, DIMER
Common Name English
RINUCUMAB [USAN]
Common Name English
REGN2176
Code English
Rinucumab [WHO-DD]
Common Name English
rinucumab [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 22:48:47 GMT 2025 , Edited by admin on Mon Mar 31 22:48:47 GMT 2025
NCI_THESAURUS C2496
Created by admin on Mon Mar 31 22:48:47 GMT 2025 , Edited by admin on Mon Mar 31 22:48:47 GMT 2025
Code System Code Type Description
INN
10175
Created by admin on Mon Mar 31 22:48:47 GMT 2025 , Edited by admin on Mon Mar 31 22:48:47 GMT 2025
PRIMARY
CAS
1569263-06-4
Created by admin on Mon Mar 31 22:48:47 GMT 2025 , Edited by admin on Mon Mar 31 22:48:47 GMT 2025
PRIMARY
ChEMBL
CHEMBL3545316
Created by admin on Mon Mar 31 22:48:47 GMT 2025 , Edited by admin on Mon Mar 31 22:48:47 GMT 2025
PRIMARY
NCI_THESAURUS
C152224
Created by admin on Mon Mar 31 22:48:47 GMT 2025 , Edited by admin on Mon Mar 31 22:48:47 GMT 2025
PRIMARY
USAN
BC-140
Created by admin on Mon Mar 31 22:48:47 GMT 2025 , Edited by admin on Mon Mar 31 22:48:47 GMT 2025
PRIMARY
SMS_ID
100000170648
Created by admin on Mon Mar 31 22:48:47 GMT 2025 , Edited by admin on Mon Mar 31 22:48:47 GMT 2025
PRIMARY
WIKIPEDIA
Rinucumab
Created by admin on Mon Mar 31 22:48:47 GMT 2025 , Edited by admin on Mon Mar 31 22:48:47 GMT 2025
PRIMARY
FDA UNII
10E3O6YI4W
Created by admin on Mon Mar 31 22:48:47 GMT 2025 , Edited by admin on Mon Mar 31 22:48:47 GMT 2025
PRIMARY
EVMPD
SUB184707
Created by admin on Mon Mar 31 22:48:47 GMT 2025 , Edited by admin on Mon Mar 31 22:48:47 GMT 2025
PRIMARY
From To
1_22 1_97
1_136 3_215
1_149 1_205
1_228 2_228
1_231 2_231
1_263 1_323
1_369 1_427
2_22 2_97
2_136 4_215
2_149 2_205
2_263 2_323
2_369 2_427
3_23 3_89
3_135 3_195
4_23 4_89
4_135 4_195
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_299
N 2_299
Related Record Type Details
PLATELET-DERIVED GROWTH FACTOR RECEPTOR BETA
INNOVATOR->PARENT
HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A
TARGET -> INHIBITOR
Related Record Type Details
RINUCUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966